Cargando…
H(1 )Antihistamines: Current Status and Future Directions
In this review, we compare and contrast the clinical pharmacology, efficacy, and safety of first-generation H(1 )antihistamines and second-generation H(1 )antihistamines. First-generation H(1 )antihistamines cross the blood-brain barrier, and in usual doses, they potentially cause sedation and impai...
Autores principales: | Simon, F Estelle R, Simons, Keith J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Allergy Organization
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3650962/ https://www.ncbi.nlm.nih.gov/pubmed/23282578 http://dx.doi.org/10.1186/1939-4551-1-9-145 |
Ejemplares similares
-
H1 antihistamines and driving
por: Florin-Dan, Popescu
Publicado: (2008) -
CSACI position statement: Newer generation H(1)-antihistamines are safer than first-generation H(1)-antihistamines and should be the first-line antihistamines for the treatment of allergic rhinitis and urticaria
por: Fein, Michael N., et al.
Publicado: (2019) -
Antipruritic Placebo Effects by Conditioning H(1)-antihistamine
por: Meeuwis, Stefanie H., et al.
Publicado: (2019) -
Cardiovascular safety of antihistamines
por: Olasińska-Wiśniewska, Anna, et al.
Publicado: (2014) -
The Pathogenesis and Management of Achalasia: Current Status and Future Directions
por: Ates, Fehmi, et al.
Publicado: (2015)